UHS estimates $175 million to $200 million impact from lower supplemental Medicaid payments in 2027
Key Facts
Universal Health Services estimated that lower supplemental Medicaid payments would have a negative impact of about $175 million to $200 million in 2027. Management said on the company’s earnings call that the impact reflects different components, including prior amounts recorded in 2026 that will not recur. The estimate also includes an initial expected impact from reduced funding for the OB3 program. The estimate puts supplemental payments at the forefront of the pressures the company identified for its operating results in 2027. Management did not describe this impact as a balance-sheet pressure.
Management said part of the estimate stems from prior amounts recorded in 2026 for DPP programs in Florida, Nevada, Ohio, California and Washington, D.C. These prior amounts factor into the comparison between what was recorded in 2026 and what the company expects the following year. The new legislative component includes about $10 million of impact in the fourth quarter of 2027. That figure is tied to the initial portion of the OB3 funding reduction related to the provider tax. The $175 million to $200 million estimate thus combines prior items that will not recur with an expected reduction whose impact begins at the end of 2027.
In addition to Medicaid, the chief financial officer identified potential pressure from health insurance exchange markets. He said annualizing the pace in the second half of 2026 would mean $15 million of pressure in 2027. He added that the impact could rise if enrollment in those markets declines. The estimate links the enrollment trajectory in the second half of 2026 with potential pressure on results the following year. Management said any further change in enrollment could increase the estimated figure.
For new facilities, the company expected its two new acute care facilities and Laurel Ridge facility to post combined operating losses of $80 million to $100 million in 2026. Management said it sees the potential to recover a significant portion of those losses in 2027. The estimate places facility losses among the operating factors whose effects will extend into next year. The company expects these facilities to remain a source of losses in 2026, with the potential to recoup a significant portion later. Management did not specify in the quote how much could be recovered.
On the near-term outlook, the company reiterated the ranges in its financial and operating guidance issued in July and said it currently expects results near the low end of those ranges. On the earnings call, management described labor trends as continuing to moderate and pointed to slower employee growth in behavioral health. It also said behavioral care volumes had improved compared with recent quarters, while indicators of demand for acute care remained favorable. These operating indicators contrasted with the financial outlook near the low end of the ranges. The company did not mention stable labor trends in its official earnings release.
The warning was reflected in premarket trading on October 28, 2026, when UHS shares fell 5.26% to $168, according to Investing.com. The stock had closed at $177.32 on October 27, according to EL7 data. The prices show the stock’s decline between the prior close and premarket trading after the results announcement and warning about 2027 pressures. The company said it plans to issue its full-year 2027 guidance in February, alongside its fourth-quarter results. That will be the company’s first comprehensive update to its outlook for next year.